These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 15885656

  • 1. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
    Sterin-Borda L, Del Zar CF, Borda E.
    Biochem Pharmacol; 2005 Jun 15; 69(12):1705-13. PubMed ID: 15885656
    [Abstract] [Full Text] [Related]

  • 2. Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.
    Sterin-Borda L, Bernabeo G, Ganzinelli S, Joensen L, Borda E.
    J Mol Cell Cardiol; 2006 Apr 15; 40(4):580-8. PubMed ID: 16510153
    [Abstract] [Full Text] [Related]

  • 3. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG.
    Int J Obes (Lond); 2006 Apr 15; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [Abstract] [Full Text] [Related]

  • 4. Neuronal nitric oxide synthase activity in rat urinary bladder detrusor: participation in M3 and M4 muscarinic receptor function.
    Orman B, Sterin-Borda L, Reina S, Borda ES.
    Auton Autacoid Pharmacol; 2005 Jul 15; 25(3):93-100. PubMed ID: 15955028
    [Abstract] [Full Text] [Related]

  • 5. Cannabinoid CB1 and CB2 receptors antagonists AM251 and AM630 differentially modulate the chronotropic and inotropic effects of isoprenaline in isolated rat atria.
    Weresa J, Pędzińska-Betiuk A, Kossakowski R, Malinowska B.
    Pharmacol Rep; 2019 Feb 15; 71(1):82-89. PubMed ID: 30500553
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlations between neuronal nitric oxide synthase and muscarinic M3/M1 receptors in the rat retina.
    Borda E, Berra A, Saravia M, Ganzinelli S, Sterin-Borda L.
    Exp Eye Res; 2005 Mar 15; 80(3):391-9. PubMed ID: 15721621
    [Abstract] [Full Text] [Related]

  • 10. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.
    Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA, Brownstein M.
    J Pharmacol Exp Ther; 1998 Jan 15; 284(1):291-7. PubMed ID: 9435190
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.
    McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA.
    Mol Pharmacol; 2008 Feb 15; 73(2):441-50. PubMed ID: 17965195
    [Abstract] [Full Text] [Related]

  • 12. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD, Williamson EM.
    J Dermatol Sci; 2007 Feb 15; 45(2):87-92. PubMed ID: 17157480
    [Abstract] [Full Text] [Related]

  • 13. [The endocannabinoid system as a novel target for the treatment of liver fibrosis].
    Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Hezode C, Mallat A, Lotersztajn S.
    Pathol Biol (Paris); 2008 Feb 15; 56(1):36-8. PubMed ID: 17412522
    [Abstract] [Full Text] [Related]

  • 14. Negative inotropic effect of carbachol on rat atria mediated by nitric oxide.
    Vila Echague A, Genaro AM, Sterin-Borda L.
    Acta Physiol Pharmacol Ther Latinoam; 1994 Feb 15; 44(3):100-7. PubMed ID: 7545028
    [Abstract] [Full Text] [Related]

  • 15. Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor.
    Steffens M, Zentner J, Honegger J, Feuerstein TJ.
    Biochem Pharmacol; 2005 Jan 01; 69(1):169-78. PubMed ID: 15588725
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J, Budhiraja S.
    Methods Find Exp Clin Pharmacol; 2006 Apr 01; 28(3):177-83. PubMed ID: 16810344
    [Abstract] [Full Text] [Related]

  • 17. The cannabinoid system and immune modulation.
    Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H.
    J Leukoc Biol; 2003 Oct 01; 74(4):486-96. PubMed ID: 12960289
    [Abstract] [Full Text] [Related]

  • 18. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M, Torbidoni V, Julián K, Prestifilippo JP, Sinha D, Rettori V, Berra A, Suburo AM.
    Invest Ophthalmol Vis Sci; 2008 Oct 01; 49(10):4535-44. PubMed ID: 18566465
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages.
    Han KH, Lim S, Ryu J, Lee CW, Kim Y, Kang JH, Kang SS, Ahn YK, Park CS, Kim JJ.
    Cardiovasc Res; 2009 Dec 01; 84(3):378-86. PubMed ID: 19596672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.